Air Doctor
-49%
est. 2Y upside i
Rank
#475
Sector
HealthTech
Est. Liquidity
~3Y
Data Quality
Data: MediumAir Doctor presents a moderate upside opportunity for a job seeker, driven by its rapid growth in a large and expanding niche market, strong insurance partnerships, and a moderate competitive moat.
Last updated: March 10, 2026
Air Doctor significantly expands its global network and deepens partnerships with major insurance providers like Allianz, leveraging its cashless/claimless experience to capture substantial market share in the growing travel health TAM. This drives revenue to over $100M by 2028, justifying a $350M+ valuation at a healthy multiple, well above the current $100M.
Air Doctor continues its steady growth, expanding its network and insurance partnerships at a moderate pace. It maintains its niche leadership but faces increasing competition, leading to revenue of ~$50M by 2028 and a valuation of approximately $175M, representing a modest return for common shareholders given the preference stack.
Increased competition or regulatory hurdles in key markets slow growth significantly, or a major insurance partner shifts strategy. Revenue growth stalls, leading to a down round or an exit at a reduced valuation of $40M, resulting in minimal to no return for common stock holders due to the substantial liquidation preferences.
Preference Stack Risk
severeInvestors hold approximately $50.9M in liquidation preferences on an estimated $100M post-money valuation.
Dilution Risk
moderateAs a Series B company, Air Doctor will likely require additional funding rounds before a liquidity event, leading to further dilution for existing equity holders.
Secondary Liquidity
noneAt the Series B stage, there is typically no active secondary market or tender offers for employee equity.
Questions to Ask at the Interview
Strategic questions based on Air Doctor's data — designed to show you've done your homework.
- 1
“Given the rapid expansion into 84 countries and partnerships with 18 major insurers, how does Air Doctor ensure consistent quality and regulatory compliance across such a diverse global network?”
- 2
“With an estimated $18M in revenue and a focus on both B2B2C and B2C models, what are the key metrics the company prioritizes for demonstrating scalable growth and unit economics to investors in the next 12-24 months?”
- 3
“Considering the Series B funding round and the current market conditions, what is the anticipated timeline and strategy for a liquidity event for employees, and how is the company addressing the implications of the preference stack on common stock value?”
Community
Valuation Sentiment
Our model estimates -49% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.